Ad is loading...
HNSBF
Price
$3.65
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
MLLCF
Price
$6.35
Change
-$0.00 (-0.00%)
Updated
Oct 24 closing price
Ad is loading...

HNSBF vs MLLCF

Header iconHNSBF vs MLLCF Comparison
Open Charts HNSBF vs MLLCFBanner chart's image
Hansa Medical AB
Price$3.65
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
Molecular Partners AG
Price$6.35
Change-$0.00 (-0.00%)
Volume$150
CapitalizationN/A
HNSBF vs MLLCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
HNSBF vs. MLLCF commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSBF is a Buy and MLLCF is a Buy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (HNSBF: $3.65 vs. MLLCF: $6.35)
Brand notoriety: HNSBF and MLLCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HNSBF: 115% vs. MLLCF: 94%
Market capitalization -- HNSBF: $182.02M vs. MLLCF: $200.71M
HNSBF [@Biotechnology] is valued at $182.02M. MLLCF’s [@Biotechnology] market capitalization is $200.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSBF’s FA Score shows that 0 FA rating(s) are green whileMLLCF’s FA Score has 0 green FA rating(s).

  • HNSBF’s FA Score: 0 green, 5 red.
  • MLLCF’s FA Score: 0 green, 5 red.
According to our system of comparison, MLLCF is a better buy in the long-term than HNSBF.

Price Growth

HNSBF (@Biotechnology) experienced а 0.00% price change this week, while MLLCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
MLLCF($201M) has a higher market cap than HNSBF($177M). HNSBF YTD gains are higher at: 61.719 vs. MLLCF (47.674). MLLCF has higher annual earnings (EBITDA): -60.16M vs. HNSBF (-559.05M). HNSBF has more cash in the bank: 554M vs. MLLCF (144M). MLLCF has less debt than HNSBF: MLLCF (2.75M) vs HNSBF (959M). HNSBF has higher revenues than MLLCF: HNSBF (189M) vs MLLCF (6M).
HNSBFMLLCFHNSBF / MLLCF
Capitalization177M201M88%
EBITDA-559.05M-60.16M929%
Gain YTD61.71947.674129%
P/E RatioN/AN/A-
Revenue189M6M3,149%
Total Cash554M144M385%
Total Debt959M2.75M34,911%
FUNDAMENTALS RATINGS
HNSBF vs MLLCF: Fundamental Ratings
HNSBF
MLLCF
OUTLOOK RATING
1..100
3732
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3937
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLLCF's Valuation (36) in the null industry is somewhat better than the same rating for HNSBF (75). This means that MLLCF’s stock grew somewhat faster than HNSBF’s over the last 12 months.

MLLCF's Profit vs Risk Rating (100) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

MLLCF's SMR Rating (96) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

MLLCF's Price Growth Rating (37) in the null industry is in the same range as HNSBF (39). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

MLLCF's P/E Growth Rating (89) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NODK16.490.47
+2.93%
NI Holdings
HES147.980.51
+0.35%
Hess Corp
ZUO9.90N/A
N/A
Zuora
TPST0.89N/A
-0.53%
Tempest Therapeutics
LU2.34-0.07
-2.90%
Lufax Holding Ltd

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
-9.65%
CVAC - HNSBF
33%
Poorly correlated
+2.81%
MLLCF - HNSBF
27%
Poorly correlated
N/A
LBPH - HNSBF
27%
Poorly correlated
N/A
ALLK - HNSBF
27%
Poorly correlated
-3.44%
More

MLLCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLLCF has been loosely correlated with ENSC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MLLCF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLLCF
1D Price
Change %
MLLCF100%
N/A
ENSC - MLLCF
37%
Loosely correlated
-9.65%
CYYNF - MLLCF
31%
Poorly correlated
N/A
HNSBF - MLLCF
27%
Poorly correlated
N/A
ALLK - MLLCF
26%
Poorly correlated
-3.44%
URGN - MLLCF
26%
Poorly correlated
+0.87%
More